 |
|
Sign in to view your progression
|
|
ON-DEMAND
Surgical outcome as prognostic factor in different histologic subtypes of ovarian carcinoma- analysis of 7 phase III trials by AGO Studygroup + ENGOT
|
|
|
ON-DEMAND
Analysis of patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer in the phase 3 ARIEL3 study
|
|
|
ON-DEMAND
Can pharmacogenetics predict chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with Taxane-based chemotherapy?
|
|
|
Q&A
Q&A
|
|
{{ help_message }}
{{filter}}